Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$75.22 +0.61 (+0.82%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Free Cash Flow (2017 - 2026)

Updated

Kiniksa Pharmaceuticals International (KNSA) reported Free Cash Flow of $46.53 million for Q2 2026, up 66.6% from $27.93 million a year earlier but down 7.0% from the prior quarter.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Free Cash Flow (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kiniksa Pharmaceuticals International's Free Cash Flow came in at $182.84 million, up 175.0% year-over-year; for FY2025, it came in at $136.42 million, up 436.8% from FY2024.

  • Free Cash Flow has increased for three consecutive years.
  • By year, Free Cash Flow came in at $25.41 million in FY2024 (+92.9%), $13.17 million in FY2023 (+131.0%), $5.7 million in FY2022 and -$126.71 million in FY2021.
  • Five-year quarterly Free Cash Flow spans a low of -$36.85 million in Q1 2022 and a high of $62.03 million in Q3 2022.
  • Year over year, Free Cash Flow has now increased in each of the last three quarters, with growth averaging 270.6% over the last six quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $50.04 million (Q1 2026), $53.26 million (Q4 2025) and $33.01 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.30 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.11 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 6.20 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 5.34 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.49 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 302.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.01 Bn
10 Kiniksa Pharmaceuticals International 11.64 Bn 10.38 Bn 220.03 Mn 46.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.53 Mn
Mar 31, 2026 50.04 Mn
Dec 31, 2025 53.26 Mn
Sep 30, 2025 33.01 Mn
Jun 30, 2025 27.93 Mn
Mar 31, 2025 22.23 Mn
Dec 31, 2024 18.58 Mn
Sep 30, 2024 -2.24 Mn
Jun 30, 2024 5.17 Mn
Mar 31, 2024 3.90 Mn
Dec 31, 2023 4.27 Mn
Sep 30, 2023 16.97 Mn
Jun 30, 2023 -3.78 Mn
Mar 31, 2023 -4.29 Mn
Dec 31, 2022 -11.54 Mn
Sep 30, 2022 62.03 Mn
Jun 30, 2022 -7.82 Mn
Mar 31, 2022 -36.85 Mn
Dec 31, 2021 -19.14 Mn
Sep 30, 2021 -28.56 Mn
API Access

Kiniksa Pharmaceuticals International Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=KNSA&period=max&api_key=YOUR_API_KEY